FT Options »

United Therapeutics Corporation shares owned by FT Options

Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by FT Options from 13F filings

Historical chart of FT Options investment in United Therapeutics Corporation

Tip: Access up to 7 years of quarterly data

All positions including United Therapeutics Corporation held by FT Options consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in United Therapeutics Corporation by FT Options

Quarter filed Position value Share count Share price at filing
2017-09-30 $33k 11k 3.08
2017-03-31 $4.2M 31k 135.35
2016-12-31 $152k 26k 5.79
2016-09-30 $579k 32k 18.33
2015-12-31 $12M 79k 156.63

More positions owned by FT Options

Incyte Corporation (INCY)
Gilead Sciences (GILD)
Clovis Oncology
iShares NASDAQ Biotechnology Index (IBB)
Insmed (INSM)
Gw Pharmaceuticals Plc ads
Tesaro
Time Warner
Abbvie (ABBV)
General Mills (GIS)
Regeneron Pharmaceuticals (REGN)
Dbv Technologies S A
Kimberly-Clark Corporation (KMB)
Zogenix
Clorox Company (CLX)

View all positions for FT Options

Top funds holding United Therapeutics Corporation

BlackRock
BlackRock
Vanguard Group
State Street Corporation
Renaissance Technologies
Geode Capital Management
LSV Asset Management
AQR Capital Management
Morgan Stanley
Arrowstreet Capital, Limited Partnership
Dimensional Fund Advisors
Hanna Zanoni
Pacer Advisors
Alliancebernstein
Nuveen Asset Management

View all funds holding United Therapeutics Corporation